Deepbridge wins 'Best New Entrant' award

Deepbridge are delighted to announce that at the Investment Week Efficiency Awards we were joint winners of the 'Best New Entrant' Award, for our Deepbridge Life Sciences EIS and Deepbridge Syndicate, along with Syndicate Room.

Following on from the success of the Deepbridge Life Sciences SEIS, which has to date raised £6.4m and will have funded over 40 seed-stage companies by the end of the tax year, Deepbridge launched the Deepbridge Life Sciences EIS in February 2017 to provide much-needed commercialisation funding for healthcare and medical technology innovation.

Ian Warwick, Managing Partner at Deepbridge, commented: 

“We are delighted that our unique approach to investing has been recognised by Investment Week. The Deepbridge Life Sciences EIS, led by Head of Life Sciences Dr Savvas Neophytou, seeks to identify life sciences innovations with the potential opportunity for high growth.  Our hands-on management style then enables our team to working closely with those companies to develop leading-edge businesses, ultimately aiming to generate real returns to our investors.  We are pleased that this approach is appreciated by those advisers and investors alike who want to know where and how their money is being invested. Any company we invest in has to be an appealing investment opportunity regardless of any tax-reliefs. The tax-reliefs potentially available under the Enterprise Investment Scheme should be considered risk mitigation for investors rather than our driver for investing.”​